Professor Cornelis Punt, chair of the Dutch Colorectal Cancer Group, discusses the multi discipline approach used by the DCCG in their work and plans for future collaborations with other groups within Europe.

Prof. Punt goes on to describe the exciting new results in their SCRIPT clinical trial, other hot topics emerging from the EMCCC conference and describes the difficulties developing new biomarkers.